Skip to main content
. 2018 Jul 23;10:2223–2229. doi: 10.2147/CMAR.S168409

Table 2.

Ultrasound features of patients with Bethesda category III TNs

Parameters A: Total study group (n=127) B: Noncancer (n=114) C: Cancer (n=13) p-value (B vs C)
Microcalcification <0.0001a
 No 99 (78.0) 96 (84.2) 3 (23.1)
 Yes 28 (22.0) 18 (15.8) 10 (76.9)
Echogenicity <0.0001a
 Hyperechoic 79 (62.2) 78 (68.4) 1 (7.7)
 Hypoechoic 48 (37.8) 36 (31.6) 12 (92.3)
Irregular margin <0.0001a
 No 83 (65.4) 82 (71.9) 1 (7.7)
 Yes 44 (34.6) 32 (28.1) 12 (92.3)
Taller than wide <0.0001a
 No 91 (71.7) 89 (78.1) 2 (15.4)
 Yes 36 (28.3) 25 (21.9) 11 (84.6)
High vascularity 0.052b
 No 61 (48.0) 58 (50.9) 3 (23.1)
 Yes 66 (52.0) 56 (49.1) 10 (76.9)
Fast growth <0.0001a
 No 91 (71.7) 89 (78.1) 2 (15.4)
 Yes 36 (28.3) 25 (21.9) 11 (84.6)
Macrocalcification 0.555
 No 74 (58.3) 65 (57.0) 9 (69.2)
 Yes 53 (41.7) 49 (43.0) 4 (30.8)

Notes:

a

Statistically significant at p<0.05;

b

tendency toward statistical significance at 0.05<p<0.1. Descriptive data are presented as number (%).

Abbreviation: TN, thyroid nodule.